Gateway Genomics
is dedicated to developing accurate, science-based prenatal and pediatric tests that give families everywhere a sneak peek into the health and development of their child.
Gateway Genomics
is dedicated to developing accurate, science-based prenatal and pediatric tests that give families everywhere a sneak peek into the heath and development of their child.
By the Numbers
Test Kits Sold
Clinical Locations
Consecutive Years on the Inc. 5000 List
Our Products
SneakPeek Gender At-Home
SneakPeek Gender At-Home is a convenient DNA test to discover a baby’s gender as early as 6 weeks into pregnancy. The test kit is sent via mail to the mother’s home, and a self-collected blood sample is returned to SneakPeek Labs in a prepaid envelope. Gender results are emailed directly, as early as the following day.
SneakPeek Gender Clinical
SneakPeek Gender Clinical is offered by participating OB/GYN offices and ultrasound studios to moms who are at least 6 weeks into pregnancy. A maternal blood sample is taken on site and sent to SneakPeek Labs. Results are emailed directly to mom as early as the following day, with no extra fuss.
SneakPeek Traits At-Home
SneakPeek Traits At-Home is an easy-to-use DNA test to learn what a baby will look like as an adult, their predicted nutrition levels and sleep behavior, sooner than ever before. The test kit is sent via mail to the parent’s home, and a self-collected saliva sample is returned to SneakPeek Labs in a prepaid envelope. Traits insights are provided in a portal with protected access only for the user’s family.
From Our Newsroom
Gateway Genomics Ranks in the Inc. 5000 List of Fastest-Growing Companies for the Fourth Consecutive Year
August 18, 2022
Read More
Gateway Genomics launches the only research-backed DNA test that provides fetal sex to pregnant mothers at 6 weeks gestational age
July 19, 2022
Read More
Gateway Genomics Expands SneakPeek Clinical with Coast-to-Coast Coverage in Canada
May 18, 2022
Read More
Gateway Genomics Surpasses 1500 Clinical Locations Across the US, UK, and Canada.
January 12, 2022
Read MoreTop Publications
SneakPeek Early Gender Test: The Earliest and Most Accurate Method for Fetal Sex Determination at 6-Weeks Gestation
Clinics Mother Child Health July 8, 2022
The SneakPeek® Early Gender Test was previously shown to be 99.9% accurate in determining fetal sex as early as seven weeks of gestation. To our knowledge, no prior study has shown fetal sex identification from maternal plasma earlier than seven weeks of gestation with high accuracy. The SneakPeek assay was further optimized to enable fetal sex identification at earlier gestations and its performance characteristics were determined at 6-weeks' gestation.
Accurate fetal sex determination from maternal blood at 7 weeks gestation
Journal of Pregnancy and Child Health October 14, 2021
Multiple studies have demonstrated SneakPeek® Early Gender Test’s ability to accurately determine fetal sex as early as 8 weeks gestation with greater than 99% accuracy. The qPCR-based assay was further optimized to determine fetal sex at 7 weeks gestation. The objective of this study was to evaluate SneakPeek’s clinical performance for noninvasive prenatal testing (NIPT) to determine fetal sex as early as 7 weeks gestation.
A Painless Microneedle-Based Push-Button Device for Early Fetal Sex Determination
International Journal of Pregnancy & Child Birth June 4, 2021
The advancement of prenatal DNA technology and growing demand for early fetal sex determination have created a need for a simple and easy-to-use blood collection device that eliminates the pain and difficulty individuals encounter when utilizing traditional methods of blood collection such as venipuncture or lancet fingerstick. In this study, Gateway Genomics, the leading provider of fetal sex testing, introduces “SneakPeek Snap”, a novel microneedle-based, self-administered blood collection device that simplifies at-home blood collection for fetal sex testing.